Jane Street’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$73.7K Sell
40,700
-25,500
-39% -$44.1K ﹤0.01% 10792
2025
Q4
$89.4K Buy
+66,200
New +$94.3K ﹤0.01% 10239
2025
Q3
Sell
-53,700
Closed -$52.1K 11481
2025
Q2
$52.1K Buy
+53,700
New +$44.5K ﹤0.01% 9156
2024
Q4
Sell
-13,400
Closed -$13.3K 10215
2024
Q3
$13.3K Sell
13,400
-135,600
-91% -$186K ﹤0.01% 9328
2024
Q2
$231K Buy
149,000
+117,400
+372% +$183K ﹤0.01% 8185
2024
Q1
$51.8K Buy
+31,600
New +$26.5K ﹤0.01% 8737
2023
Q2
Sell
-19,500
Closed -$16.6K 9299
2023
Q1
$16.6K Sell
19,500
-172,300
-90% -$188K ﹤0.01% 8676
2022
Q4
$249K Sell
191,800
-94,800
-33% -$148K ﹤0.01% 7325
2022
Q3
$510K Sell
286,600
-126,800
-31% -$316K ﹤0.01% 6660
2022
Q2
$938K Sell
413,400
-296,800
-42% -$710K ﹤0.01% 5592
2022
Q1
$2.34M Sell
710,200
-117,100
-14% -$411K ﹤0.01% 4442
2021
Q4
$3.76M Sell
827,300
-752,000
-48% -$5.68M ﹤0.01% 3299
2021
Q3
$11.3M Sell
1,579,300
-1,246,400
-44% -$9.15M ﹤0.01% 1651
2021
Q2
$22.7M Buy
2,825,700
+2,281,000
+419% +$19.2M 0.01% 986
2021
Q1
$3.7M Buy
+544,700
New +$3.62M ﹤0.01% 2872

Other funds holding OCGN

Jane Street's OCGN Position: Q1 2026 in Review

Jane Street increased its Ocugen (OCGN) stake by 117% in Q1 2026, buying an estimated $3.44M and bringing the position to 3,678,655 shares worth $6.66M. The position accounts for ﹤0.01% of the portfolio, ranked #3096.

Jane Street first reported a position in OCGN in Q3 2018 and has held it in 23 quarters since. The position peaked at $7.95M in Q2 2021. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

  • Jane Street held 3,678,655 shares of Ocugen worth $6.66M as of Q1 2026.
  • Jane Street bought 1,986,521 Ocugen shares in Q1 2026, an estimated $3.44M.
  • Ocugen made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3096 holding.
  • Jane Street first reported a position in Ocugen in Q3 2018 and has held it in 23 quarters since.
  • Jane Street's Ocugen position peaked at $7.95M in Q2 2021.
  • 137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.